Clinical trial
Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI
NCT01885702 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 31, 2010
- Completion date
- September 30, 2025
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer